Vanguard National Trust
PFE icon

Vanguard National Trust’s Pfizer PFE Stock Holding History

Vanguard National Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
12,807
+200
+2% +$5.23K 0.02% 227
2026
Q1 		$354K Buy
+12,607
New +$336K 0.02% 202

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard National Trust's PFE Position: Q2 2026 in Review

Vanguard National Trust increased its Pfizer (PFE) stake by 1.6% in Q2 2026, buying an estimated $5.23K and bringing the position to 12,807 shares worth $308K. The position accounts for 0.02% of the portfolio, ranked #227.

Vanguard National Trust first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $354K in Q1 2026. 2,805 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vanguard National Trust held 12,807 shares of Pfizer worth $308K as of Q2 2026.
  • Vanguard National Trust bought 200 Pfizer shares in Q2 2026, an estimated $5.23K.
  • Pfizer made up 0.02% of Vanguard National Trust's portfolio in Q2 2026, its #227 holding.
  • Vanguard National Trust first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Vanguard National Trust's Pfizer position peaked at $354K in Q1 2026.
  • 2,805 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.